High-dose topical calcipotriol in the treatment of extensive psoriasis vulgaris
- 1 July 1993
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 129 (1) , 74-76
- https://doi.org/10.1111/j.1365-2133.1993.tb03315.x
Abstract
Summary Ten patients with extensive plaque psoriasis were treated with calcipotriol ointment (50 μg/g) for 2 weeks (200 g for 1 week, followed by 300 g during the second week). Mean improvement in psoriasis area and severity index (PASI) was 71%. Mean 24 h urine calcium rose from 4.79 mmol/24 h to 7.27 mmol/24 h (P<0.000l). Urine calcium returned towards baseline after stopping calcipotriol. Mean serum calcium also rose slightly, hut significantly, from 2.26 mmol/l to 2.32 mmol/l (P<0.005). and fell again in the washout phase. Individual serum calcium values remained within the normal range throughout the study. Topical calcipotriol is an effective, rapidly acting and safe in-patient treatment for extensive plaque psoriasis.Keywords
This publication has 8 references indexed in Scilit:
- Vitamin D analogues and psoriasisBritish Journal of Dermatology, 1992
- Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgarisJournal of the American Academy of Dermatology, 1992
- Calcipotriol and hypercalcaemiaPublished by Elsevier ,1991
- Efficacy of cyclosporin A in psoriasis: a summary of the United States' experienceBritish Journal of Dermatology, 1990
- Etretinate in severe psoriasis: Results of double-blind study and maintenance therapy in pustular psoriasisJournal of the American Academy of Dermatology, 1983
- ORAL 8-METHOXYPSORALEN PHOTOCHEMOTHERAPY OF PSORIASISThe Lancet, 1981
- The Approach to PsoriasisBMJ, 1953
- TREATMENT OF PSORIASISArchives of Dermatology and Syphilology, 1931